VNDA Financial Statements | Balance Sheet, Income & Cash Flow Analysis
The financial statements for VNDA (VNDA) provide a snapshot of revenue trends, balance-sheet strength, and cash flow quality. Reviewing these together helps investors evaluate earnings durability, capital structure, and whether operating cash flow supports long-term business growth.
See stock fair value and complete historical financials—premium unlocks deeper tables and metrics.
Financial Statements
Related peers
Compare More →| IMRX Immuneering Corporation | $5.75 +6.28% |
| D Dominion Energy, Inc. | $62.38 -2.09% |
| TRDA Entrada Therapeutics, Inc. | $13.99 -0.29% |
| ACHV Achieve Life Sciences, Inc. | $3.55 -1.66% |
| V Visa Inc. | $315.91 +1.46% |
| ARCT Arcturus Therapeutics Holdings Inc. | $8.62 -0.69% |
| Peer | Price | Change | Market Cap | PE | EPS | Div Yield (TTM) | Analyst Rating | Volume |
|---|---|---|---|---|---|---|---|---|
| IMRX Immuneering Corporation | $5.75 | +6.28% | 208.74 M | -4.53 | -1.27 | 0.00% | Buy | 893 |
| D Dominion Energy, Inc. | $62.38 | -2.09% | 54.83 B | 17.98 | 3.47 | 2.14% | Hold | 4.64 |
| TRDA Entrada Therapeutics, Inc. | $13.99 | -0.29% | 535.60 M | -4.03 | -3.47 | 0.00% | Buy | 79 |
| ACHV Achieve Life Sciences, Inc. | $3.55 | -1.66% | 189.00 M | -2.84 | -1.25 | 0.00% | Buy | 2.13 |
| V Visa Inc. | $315.91 | +1.46% | 609.09 B | 29.66 | 10.65 | 0.80% | Buy | 4.82 |
| ARCT Arcturus Therapeutics Holdings Inc. | $8.62 | -0.69% | 245.01 M | -3.53 | -2.44 | 0.00% | Buy | 361 |
Frequently Asked Questions
What are VNDA's latest financial results?
Review VNDA's latest balance sheet, income statement, and cash flow to understand its profitability, revenue trends, and financial health. These metrics are essential for evaluating short-term performance and long-term stability.
How has VNDA's revenue and net income changed over time?
Analyzing historical revenue and net income shows growth trends and business performance. Consistent growth indicates operational strength, while declines may signal challenges that investors should consider.
What is VNDA's cash flow situation and liquidity?
Cash flow statements reveal how VNDA generates and uses cash. Strong operating cash flow and sufficient liquidity suggest the company can fund operations, pay dividends, and handle debt effectively.
How does VNDA's financial performance compare to industry peers?
Comparing key metrics like revenue growth, profit margins, and debt levels with competitors helps investors assess whether VNDA is outperforming or lagging within its sector.
Are VNDA's financial statements showing sustainable profitability?
By analyzing margins, ROE, ROIC, and cash generation over multiple periods, investors can evaluate whether VNDA's profits are repeatable and supported by strong fundamentals.